Frank Runkel

Prof. Frank Runkel is a faculty member at the Central Hesse University of Applied Sciences, Department of LSE, leading the Institute of Bioprocess Engineering and Pharmaceutical Technology (AG-BPT). His research focuses on pharmaceutical technology, drug delivery systems, and biomedical applications.

• Education: PhD in Pharmaceutical Chemistry (1988), Philipps-Universität Marburg

Research interests span drug delivery via DNAzymes, dermal formulations, 3D printing in pharmaceuticals, and allergy immunotherapy. Recent projects integrate bioink development with cell therapy for diabetes.

Key publication trends include topical RNA delivery, biofilm disruption, and advanced microemulsion techniques, reflecting his expertise in nanotechnology and dermatological applications.

• Scientific Awards: None explicitly mentioned

Advising highlights include mentoring 10+ PhD candidates in areas like DNAzyme therapy, 3D-printed dosage forms, and insect-derived wound treatments. Grants from THM Strategic Research Fund, BMBF, and BWMK support his work on oral biologics, sustainable cleanrooms, and innovative excipients.

Labs/teams: AG-BPT (Biopharmaceutical Technology Working Group) at THM